94.05
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $94.05, with a volume of 1.29M.
It is up +2.83% in the last 24 hours and up +12.82% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$91.46
Open:
$92.09
24h Volume:
1.29M
Relative Volume:
1.01
Market Cap:
$10.92B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
40.02
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+11.88%
1M Performance:
+12.82%
6M Performance:
-6.65%
1Y Performance:
-24.21%
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RVTY
Revvity Inc
|
94.05 | 10.62B | 2.77B | 286.61M | 524.11M | 2.35 |
![]()
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-01-25 | Upgrade | UBS | Neutral → Buy |
Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jul-08-24 | Initiated | Leerink Partners | Outperform |
Jun-03-24 | Resumed | Jefferies | Hold |
Jan-16-24 | Downgrade | UBS | Buy → Neutral |
Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
Sep-28-23 | Initiated | Bernstein | Outperform |
Jul-19-23 | Initiated | Raymond James | Outperform |
May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Using AI based signals to follow Revvity Inc.Weekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Can a trend reversal in Revvity Inc. lead to recoveryQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com
Revvity to develop type 1 diabetes early detection assay with Sanofi - Investing.com Nigeria
Chart based analysis of Revvity Inc. trendsJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Is Revvity Inc. stock undervalued vs historical averagesLong Setup & Accurate Entry/Exit Alerts - newser.com
Revvity Inc. stock trend outlook and recovery path2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Is Revvity Inc. stock a top pick for value investorsGlobal Markets & Weekly Momentum Stock Picks - newser.com
Automated trading signals detected on Revvity Inc.Trade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Order flow analysis tools used on Revvity Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Will Revvity Inc. (PKN) stock enhance shareholder valueDay Trade & Expert Approved Trade Ideas - newser.com
Lucem, Revvity partner with Sanofi for early T1D detection - BioWorld MedTech
Barclays Adjusts Revvity (RVTY) Price Target, Maintains Overweig - GuruFocus
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes - PharmiWeb.com
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Expands Type 1 Diabetes Program With Sanofi Support - Nasdaq
Sanofi (SNY) Supports Revvity's Expansion in Type 1 Diabetes Ass - GuruFocus
Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering - MarketScreener
Barclays Adjusts Price Target on Revvity to $100 From $110, Maintains Overweight Rating - MarketScreener
How Revvity Inc. (PKN) stock reacts to Fed tighteningJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Will Revvity Inc. stock sustain high P E ratiosJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - The Globe and Mail
Revvity Launches AI Software Transforming Preclinical Imaging - Precedence Research
How to recover losses in Revvity Inc. stockRate Cut & High Conviction Buy Zone Alerts - newser.com
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener
Revvity (RVTY) Unveils Advanced AI Imaging Software for Researchers - GuruFocus
Revvity launches AI-powered multimodal analysis software for imaging research By Investing.com - Investing.com South Africa
Revvity launches AI-powered multimodal analysis software for imaging research - Investing.com
Revvity, Inc. Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now? - Yahoo Finance
Revvity Inc PKN Stock Analysis and ForecastMarket Sentiment Shifts & Affordable Portfolio Trading - earlytimes.in
Is Revvity Inc PKN a good long term investmentDouble Top/Bottom Patterns & High Return Portfolio Growth - earlytimes.in
What analysts say about Revvity Inc stockGlobal Trade Effects & Affordable Trading Strategies - earlytimes.in
Published on: 2025-09-27 18:11:56 - newser.com
Does AI Enzyme Partnership Mark a Turning Point for Revvity’s (RVTY) Clinical Growth Ambitions? - Sahm
What drives Revvity Inc PKN stock priceInstitutional Holding Changes & Small Budget Trading Portfolio - earlytimes.in
Revvity Stock: Is RVTY Underperforming the Healthcare Sector? - MSN
Revvity (RVTY) Receives a Buy from Bank of America Securities - The Globe and Mail
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Sys - PharmiWeb.com
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):